
Acquired Hemophilia
Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Document
This fact sheet contains commonly asked questions and more information on hemostatic rebalancing therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an

This report reviews the spectrum of indications of desmopressin in the treatment of bleeding disorders.

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

Also Available In: Japanese Access to a comprehensive hemophilia treatment centre (HTC) is a critical component of care. This fact